We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Medidata Solutions Inc | NASDAQ:MDSO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 92.22 | 92.24 | 92.25 | 0 | 01:00:00 |
Medidata (NASDAQ:MDSO) today announced that it will release its first quarter 2019 financial results before the market opens on Tuesday, April 30, 2019. The company will also hold a conference call at 8 a.m. ET for the investment community to discuss the company’s results.
Conference ID: 9260289 Live dial-in: 1-877-791-0148, domestic 1-647-689-5652, international Webcast:investors.medidata.com
Replay: 1-800-585-8367, domestic 1-416-621-4642, internationalAbout Medidata
Medidata is leading the digital transformation of life sciences, with the world's most-used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by the #1 ranked industry experts, Medidata helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata and its companies, Acorn AI and SHYFT, serve more than 1,200 customers and partners worldwide and empower more than 150,000 certified users every day to create hope for millions of patients. Discover the future of life sciences: www.medidata.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190416005537/en/
Medidata Solutions:Investors:Betsy Frank, 917-522-4620bfrank@medidata.comorMedia:Erik Snider, 646-362-2997esnider@medidata.com
1 Year Medidata Solutions Chart |
1 Month Medidata Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions